Published: September 4th, 2023,
Last updated: December 12th, 2023
The Commission has granted approval for the adapted Covid-19 vaccine Comirnaty XBB.1.5, developed by BioNTech Pfizer. This vaccine is the third adaptation in response to new Covid variants.